The Effect of Intravenous Vitamin C Infusion on Periprocedural Myocardial Injury for Patients Undergoing Elective Percutaneous Coronary Intervention

Califf, 1998, Myonecrosis after revascularization procedures, J Am Coll Cardiol, 31, 241, 10.1016/S0735-1097(97)00506-8 Abdelemeguid, 1996, Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions, Circulation, 94, 1528, 10.1161/01.CIR.94.7.1528 Pervaiz, 2012, Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions, Circ Cardiovasc Interv, 5, 150, 10.1161/CIRCINTERVENTIONS.111.965566 Prasad, 2009, J Am Coll Cardiol, 54, 477, 10.1016/j.jacc.2009.03.063 Fuchs, 2000, Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions, Am J Cardiol, 85, 1077, 10.1016/S0002-9149(00)00699-8 Jeremias, 2004, Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures, J Am Coll Cardiol, 44, 1210, 10.1016/j.jacc.2004.06.051 Lindsey, 2011, Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry, Circ Cardiovasc Interv, 4, 474, 10.1161/CIRCINTERVENTIONS.111.962233 Akkerhuis, 2002, Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?, Circulation, 105, 554, 10.1161/hc0502.104278 Novack, 2012, Troponin criteria for myocardial infarction after percutaneous coronary intervention, Arch Intern Med, 172, 502, 10.1001/archinternmed.2011.2275 Kong, 1997, Prognostic implication of creatine kinase elevation following elective coronary artery interventions, JAMA, 277, 461, 10.1001/jama.1997.03540300029029 Ioannidis, 2003, Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention, J Am Coll Cardiol, 42, 1406, 10.1016/S0735-1097(03)01044-1 Prasad, 2006, Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality, J Am Coll Cardiol, 48, 1765, 10.1016/j.jacc.2006.04.102 Iuliano, 2001, Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA, J Am Coll Cardiol, 37, 76, 10.1016/S0735-1097(00)01040-8 Basili, 2010, Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers, JACC Cardiovasc Interv, 3, 221, 10.1016/j.jcin.2009.10.025 Thygesen, 2012, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction, Eur Heart J, 33, 2551, 10.1093/eurheartj/ehs184 2011, 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, J Am Coll Cardiol, 58, e44 Reilly, 1997, Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans, Circulation, 96, 3314, 10.1161/01.CIR.96.10.3314 Kaminski, 2008, Oxidative stress and antioxidative defense parameters early after reperfusion therapy for acute myocardial infarction, Acute Card Care, 10, 121, 10.1080/17482940701744334 Pignatelli, 2011, Ascorbic acid infusion blunts CD40L upregulation in patients undergoing coronary stent, Cardiovasc Ther, 29, 385, 10.1111/j.1755-5922.2010.00168.x Farah, 2008, Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention, Minerva Cardioangiol, 56, 189 Hozawa, 2007, Clin Chem, 53, 447, 10.1373/clinchem.2006.074930 Sinha, 2003, Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention, Circulation, 107, 2403, 10.1161/01.CIR.0000072764.18315.6B Spargias, 2004, Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention, Circulation, 110, 2837, 10.1161/01.CIR.0000146396.19081.73 Tomoda, 1996, Possible prevention of postangioplasty restenosis by ascorbic acid, Am J Cardiol, 78, 1284, 10.1016/S0002-9149(96)00613-3 Albabtain, 2013, Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study, J Interv Cardiol, 26, 90, 10.1111/j.1540-8183.2012.00767.x Zhou, 2012, Prevention of contrast-induced nephropathy with ascorbic acid, Intern Med, 51, 531, 10.2169/internalmedicine.51.6260 Jo, 2009, N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study—a prospective randomized controlled trial, Am Heart J, 157, 576, 10.1016/j.ahj.2008.11.010 Boscheri, 2007, Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction, Clin Nephrol, 68, 279, 10.5414/CNP68279